1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Vinorelbine Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Oral 1.2.3 Injection 1.3 Market Segment by Application 1.3.1 Global Vinorelbine Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Breast Cancer 1.3.3 Non-small Cell Lung Cancer 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Vinorelbine Market Size (2017-2028) 2.1.1 Global Vinorelbine Revenue (2017-2028) 2.1.2 Global Vinorelbine Sales (2017-2028) 2.2 Global Vinorelbine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Vinorelbine Sales by Regions (2017-2022) 2.2.2 Global Vinorelbine Revenue by Regions (2017-2022) 2.3 Global Vinorelbine Market Size Forecast by Region 2.3.1 Global Vinorelbine Sales Forecast by Region (2023-2028) 2.3.2 Global Vinorelbine Revenue Forecast by Region (2023-2028) 2.4 Global Top Vinorelbine Regions (Countries) Ranking by Market Size 2.5 Vinorelbine Market Dynamics 2.5.1 Vinorelbine Market Trends 2.5.2 Vinorelbine Market Drivers 2.5.3 Vinorelbine Market Challenges 2.5.4 Vinorelbine Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Vinorelbine Manufacturers by Sales (2017-2022) 3.1.1 Global Vinorelbine Sales by Manufacturers (2017-2022) 3.1.2 Global Vinorelbine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Vinorelbine Sales in 2021 3.2 Global Top Manufacturers Vinorelbine by Revenue 3.2.1 Global Vinorelbine Revenue by Manufacturers (2017-2022) 3.2.2 Top Vinorelbine Manufacturers Covered: Ranking by Revenue 3.2.3 Global Vinorelbine Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Vinorelbine Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vinorelbine as of 2021) 3.4 Global Vinorelbine Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Vinorelbine Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Vinorelbine Market 3.7 Key Manufacturers Vinorelbine Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Vinorelbine Market Size by Type 4.1 Global Vinorelbine Historic Market Review by Type (2017-2022) 4.1.1 Global Vinorelbine Sales Market Share by Type (2017-2022) 4.1.2 Global Vinorelbine Revenue Market Share by Type (2017-2022) 4.1.3 Vinorelbine Price by Type (2017-2022) 4.2 Global Vinorelbine Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Vinorelbine Sales Forecast by Type (2023-2028) 4.2.2 Global Vinorelbine Revenue Forecast by Type (2023-2028) 4.2.3 Vinorelbine Price Forecast by Type (2023-2028) 5 Global Vinorelbine Market Size by Application 5.1 Global Vinorelbine Historic Market Review by Application (2017-2022) 5.1.1 Global Vinorelbine Sales Market Share by Application (2017-2022) 5.1.2 Global Vinorelbine Revenue Market Share by Application (2017-2022) 5.1.3 Vinorelbine Price by Application (2017-2022) 5.2 Global Vinorelbine Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Vinorelbine Sales Forecast by Application (2023-2028) 5.2.2 Global Vinorelbine Revenue Forecast by Application (2023-2028) 5.2.3 Vinorelbine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Vinorelbine Sales Breakdown by Company 6.1.1 North America Vinorelbine Sales by Company (2017-2022) 6.1.2 North America Vinorelbine Revenue by Company (2017-2022) 6.2 North America Vinorelbine Market Size by Type 6.2.1 North America Vinorelbine Sales by Type (2017-2028) 6.2.2 North America Vinorelbine Revenue by Type (2017-2028) 6.3 North America Vinorelbine Market Size by Application 6.3.1 North America Vinorelbine Sales by Application (2017-2028) 6.3.2 North America Vinorelbine Revenue by Application (2017-2028) 6.4 North America Vinorelbine Market Size by Country 6.4.1 North America Vinorelbine Sales by Country (2017-2028) 6.4.2 North America Vinorelbine Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Vinorelbine Sales Breakdown by Company 7.1.1 Europe Vinorelbine Sales by Company (2017-2022) 7.1.2 Europe Vinorelbine Revenue by Company (2017-2022) 7.2 Europe Vinorelbine Market Size by Type 7.2.1 Europe Vinorelbine Sales by Type (2017-2028) 7.2.2 Europe Vinorelbine Revenue by Type (2017-2028) 7.3 Europe Vinorelbine Market Size by Application 7.3.1 Europe Vinorelbine Sales by Application (2017-2028) 7.3.2 Europe Vinorelbine Revenue by Application (2017-2028) 7.4 Europe Vinorelbine Market Size by Country 7.4.1 Europe Vinorelbine Sales by Country (2017-2028) 7.4.2 Europe Vinorelbine Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Vinorelbine Sales Breakdown by Company 8.1.1 Asia Pacific Vinorelbine Sales by Company (2017-2022) 8.1.2 Asia Pacific Vinorelbine Revenue by Company (2017-2022) 8.2 Asia Pacific Vinorelbine Market Size by Type 8.2.1 Asia Pacific Vinorelbine Sales by Type (2017-2028) 8.2.2 Asia Pacific Vinorelbine Revenue by Type (2017-2028) 8.3 Asia Pacific Vinorelbine Market Size by Application 8.3.1 Asia Pacific Vinorelbine Sales by Application (2017-2028) 8.3.2 Asia Pacific Vinorelbine Revenue by Application (2017-2028) 8.4 Asia Pacific Vinorelbine Market Size by Region 8.4.1 Asia Pacific Vinorelbine Sales by Region 8.4.2 Asia Pacific Vinorelbine Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Vinorelbine Sales Breakdown by Company 9.1.1 Latin America Vinorelbine Sales by Company (2017-2022) 9.1.2 Latin America Vinorelbine Revenue by Company (2017-2022) 9.2 Latin America Vinorelbine Market Size by Type 9.2.1 Latin America Vinorelbine Sales by Type (2017-2028) 9.2.2 Latin America Vinorelbine Revenue by Type (2017-2028) 9.3 Latin America Vinorelbine Market Size by Application 9.3.1 Latin America Vinorelbine Sales by Application (2017-2028) 9.3.2 Latin America Vinorelbine Revenue by Application (2017-2028) 9.4 Latin America Vinorelbine Market Size by Country 9.4.1 Latin America Vinorelbine Sales by Country (2017-2028) 9.4.2 Latin America Vinorelbine Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Vinorelbine Sales Breakdown by Company 10.1.1 Middle East and Africa Vinorelbine Sales by Company (2017-2022) 10.1.2 Middle East and Africa Vinorelbine Revenue by Company (2017-2022) 10.2 Middle East and Africa Vinorelbine Market Size by Type 10.2.1 Middle East and Africa Vinorelbine Sales by Type (2017-2028) 10.2.2 Middle East and Africa Vinorelbine Revenue by Type (2017-2028) 10.3 Middle East and Africa Vinorelbine Market Size by Application 10.3.1 Middle East and Africa Vinorelbine Sales by Application (2017-2028) 10.3.2 Middle East and Africa Vinorelbine Revenue by Application (2017-2028) 10.4 Middle East and Africa Vinorelbine Market Size by Country 10.4.1 Middle East and Africa Vinorelbine Sales by Country (2017-2028) 10.4.2 Middle East and Africa Vinorelbine Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 U.A.E 11 Company Profiles 11.1 Pierre Fabre Pharmaceuticals, Inc. 11.1.1 Pierre Fabre Pharmaceuticals, Inc. Corporation Information 11.1.2 Pierre Fabre Pharmaceuticals, Inc. Overview 11.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Products and Services 11.1.5 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine SWOT Analysis 11.1.6 Pierre Fabre Pharmaceuticals, Inc. Recent Developments 11.2 TEVA Pharms 11.2.1 TEVA Pharms Corporation Information 11.2.2 TEVA Pharms Overview 11.2.3 TEVA Pharms Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 TEVA Pharms Vinorelbine Products and Services 11.2.5 TEVA Pharms Vinorelbine SWOT Analysis 11.2.6 TEVA Pharms Recent Developments 11.3 Hospira, Inc. 11.3.1 Hospira, Inc. Corporation Information 11.3.2 Hospira, Inc. Overview 11.3.3 Hospira, Inc. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Hospira, Inc. Vinorelbine Products and Services 11.3.5 Hospira, Inc. Vinorelbine SWOT Analysis 11.3.6 Hospira, Inc. Recent Developments 11.4 West-Ward Pharmaceuticals Corp. 11.4.1 West-Ward Pharmaceuticals Corp. Corporation Information 11.4.2 West-Ward Pharmaceuticals Corp. Overview 11.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 West-Ward Pharmaceuticals Corp. Vinorelbine Products and Services 11.4.5 West-Ward Pharmaceuticals Corp. Vinorelbine SWOT Analysis 11.4.6 West-Ward Pharmaceuticals Corp. Recent Developments 11.5 Fresenius Kabi 11.5.1 Fresenius Kabi Corporation Information 11.5.2 Fresenius Kabi Overview 11.5.3 Fresenius Kabi Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Fresenius Kabi Vinorelbine Products and Services 11.5.5 Fresenius Kabi Vinorelbine SWOT Analysis 11.5.6 Fresenius Kabi Recent Developments 11.6 EBEWE Pharma (Sandoz A Novartis Division) 11.6.1 EBEWE Pharma (Sandoz A Novartis Division) Corporation Information 11.6.2 EBEWE Pharma (Sandoz A Novartis Division) Overview 11.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Products and Services 11.6.5 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine SWOT Analysis 11.6.6 EBEWE Pharma (Sandoz A Novartis Division) Recent Developments 11.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. 11.7.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information 11.7.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Overview 11.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Products and Services 11.7.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine SWOT Analysis 11.7.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments 11.8 Mylan 11.8.1 Mylan Corporation Information 11.8.2 Mylan Overview 11.8.3 Mylan Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Mylan Vinorelbine Products and Services 11.8.5 Mylan Vinorelbine SWOT Analysis 11.8.6 Mylan Recent Developments 11.9 Dr. Reddy's Laboratories 11.9.1 Dr. Reddy's Laboratories Corporation Information 11.9.2 Dr. Reddy's Laboratories Overview 11.9.3 Dr. Reddy's Laboratories Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Dr. Reddy's Laboratories Vinorelbine Products and Services 11.9.5 Dr. Reddy's Laboratories Vinorelbine SWOT Analysis 11.9.6 Dr. Reddy's Laboratories Recent Developments 11.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. 11.10.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Corporation Information 11.10.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Overview 11.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Products and Services 11.10.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine SWOT Analysis 11.10.6 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Developments 11.11 Nanjing Cuccess Pharmaceutical Co., Ltd 11.11.1 Nanjing Cuccess Pharmaceutical Co., Ltd Corporation Information 11.11.2 Nanjing Cuccess Pharmaceutical Co., Ltd Overview 11.11.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Products and Services 11.11.5 Nanjing Cuccess Pharmaceutical Co., Ltd Recent Developments 11.12 Qilu Pharmaceutical (Hainan) Co., Ltd. 11.12.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information 11.12.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Overview 11.12.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Products and Services 11.12.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments 11.13 Sinopharm A-Think Pharmaceutical Co., Ltd. 11.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Corporation Information 11.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Overview 11.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Products and Services 11.13.5 Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Developments 11.14 Beijing SL Pharm 11.14.1 Beijing SL Pharm Corporation Information 11.14.2 Beijing SL Pharm Overview 11.14.3 Beijing SL Pharm Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Beijing SL Pharm Vinorelbine Products and Services 11.14.5 Beijing SL Pharm Recent Developments 11.15 Shenzhen Main Luck Pharmaceuticals Inc. 11.15.1 Shenzhen Main Luck Pharmaceuticals Inc. Corporation Information 11.15.2 Shenzhen Main Luck Pharmaceuticals Inc. Overview 11.15.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.15.4 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Products and Services 11.15.5 Shenzhen Main Luck Pharmaceuticals Inc. Recent Developments 11.16 Shanxi Powerdone Pharmaceutics Co., Ltd. 11.16.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Corporation Information 11.16.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Overview 11.16.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.16.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Products and Services 11.16.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments 11.17 Luoxin Pharmaceutical Group Co., Ltd. 11.17.1 Luoxin Pharmaceutical Group Co., Ltd. Corporation Information 11.17.2 Luoxin Pharmaceutical Group Co., Ltd. Overview 11.17.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.17.4 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Products and Services 11.17.5 Luoxin Pharmaceutical Group Co., Ltd. Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Vinorelbine Value Chain Analysis 12.2 Vinorelbine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Vinorelbine Production Mode & Process 12.4 Vinorelbine Sales and Marketing 12.4.1 Vinorelbine Sales Channels 12.4.2 Vinorelbine Distributors 12.5 Vinorelbine Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Vinorelbine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Oral Table 3. Major Manufacturers of Injection Table 4. Global Vinorelbine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Vinorelbine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Vinorelbine Sales by Region (2017-2022) & (MT) Table 7. Global Vinorelbine Sales Market Share by Region (2017-2022) Table 8. Global Vinorelbine Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Vinorelbine Revenue Market Share by Region (2017-2022) Table 10. Global Vinorelbine Sales Forecast by Region (2023-2028) & (MT) Table 11. Global Vinorelbine Sales Market Share Forecast by Region (2023-2028) Table 12. Global Vinorelbine Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global Vinorelbine Revenue Market Share Forecast by Region (2023-2028) Table 14. Top Vinorelbine Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. Vinorelbine Market Trends Table 16. Vinorelbine Market Drivers Table 17. Vinorelbine Market Challenges Table 18. Vinorelbine Market Restraints Table 19. Global Vinorelbine Sales by Manufacturers (2017-2022) & (MT) Table 20. Global Vinorelbine Sales Share by Manufacturers (2017-2022) Table 21. Global Vinorelbine Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top Vinorelbine Manufacturers by Revenue (US$ Million) in 2021 Table 23. Vinorelbine Revenue Share by Manufacturers (2017-2022) Table 24. Global Vinorelbine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vinorelbine as of 2021) Table 26. Key Manufacturers Vinorelbine Average Selling Price (ASP) & (2017-2022) & (USD/Kg) Table 27. Key Manufacturers Vinorelbine Plants/Factories Distribution Table 28. Key Manufacturers Vinorelbine Area Served Table 29. Date of Key Manufacturers Enter into Vinorelbine Market Table 30. Key Manufacturers Vinorelbine Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Vinorelbine Sales (MT) by Type (2017-2022) Table 33. Global Vinorelbine Sales Share by Type (2017-2022) Table 34. Global Vinorelbine Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global Vinorelbine Price (MT) by Type (2017-2022) Table 36. Global Vinorelbine Sales (MT) by Type (2023-2028) Table 37. Global Vinorelbine Sales Share by Type (2023-2028) Table 38. Global Vinorelbine Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global Vinorelbine Revenue Share by Type (2023-2028) Table 40. Global Vinorelbine Price (MT) by Type (2023-2028) Table 41. Global Vinorelbine Sales (MT) by Application (2017-2022) Table 42. Global Vinorelbine Sales Share by Application (2017-2022) Table 43. Global Vinorelbine Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global Vinorelbine Price (MT) by Application (2017-2022) Table 45. Global Vinorelbine Sales (MT) by Application (2023-2028) Table 46. Global Vinorelbine Sales Share by Application (2023-2028) Table 47. Global Vinorelbine Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global Vinorelbine Revenue Share by Application (2023-2028) Table 49. Global Vinorelbine Price (MT) by Application (2023-2028) Table 50. North America Vinorelbine Sales by Company (2017-2022) & (MT) Table 51. North America Vinorelbine Sales Market Share by Company (2017-2022) Table 52. North America Vinorelbine Revenue by Company (2017-2022) & (US$ Million) Table 53. North America Vinorelbine Revenue Market Share by Company (2017-2022) Table 54. North America Vinorelbine Sales by Type (2017-2022) & (MT) Table 55. North America Vinorelbine Sales by Type (2023-2028) & (MT) Table 56. North America Vinorelbine Revenue by Type (2017-2022) & (US$ Million) Table 57. North America Vinorelbine Revenue by Type (2023-2028) & (US$ Million) Table 58. North America Vinorelbine Sales by Application (2017-2022) & (MT) Table 59. North America Vinorelbine Sales by Application (2023-2028) & (MT) Table 60. North America Vinorelbine Revenue by Application (2017-2022) & (US$ Million) Table 61. North America Vinorelbine Revenue by Application (2023-2028) & (US$ Million) Table 62. North America Vinorelbine Sales by Country (2017-2022) & (MT) Table 63. North America Vinorelbine Sales by Country (2023-2028) & (MT) Table 64. North America Vinorelbine Revenue by Country (2017-2022) & (US$ Million) Table 65. North America Vinorelbine Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe Vinorelbine Sales by Company (2017-2022) & (MT) Table 67. Europe Vinorelbine Sales Market Share by Company (2017-2022) Table 68. Europe Vinorelbine Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe Vinorelbine Revenue Market Share by Company (2017-2022) Table 70. Europe Vinorelbine Sales by Type (2017-2022) & (MT) Table 71. Europe Vinorelbine Sales by Type (2023-2028) & (MT) Table 72. Europe Vinorelbine Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe Vinorelbine Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe Vinorelbine Sales by Application (2017-2022) & (MT) Table 75. Europe Vinorelbine Sales by Application (2023-2028) & (MT) Table 76. Europe Vinorelbine Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe Vinorelbine Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe Vinorelbine Sales by Country (2017-2022) & (MT) Table 79. Europe Vinorelbine Sales by Country (2023-2028) & (MT) Table 80. Europe Vinorelbine Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe Vinorelbine Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific Vinorelbine Sales by Company (2017-2022) & (MT) Table 83. Asia Pacific Vinorelbine Sales Market Share by Company (2017-2022) Table 84. Asia Pacific Vinorelbine Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific Vinorelbine Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific Vinorelbine Sales by Type (2017-2022) & (MT) Table 87. Asia Pacific Vinorelbine Sales by Type (2023-2028) & (MT) Table 88. Asia Pacific Vinorelbine Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific Vinorelbine Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific Vinorelbine Sales by Application (2017-2022) & (MT) Table 91. Asia Pacific Vinorelbine Sales by Application (2023-2028) & (MT) Table 92. Asia Pacific Vinorelbine Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific Vinorelbine Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific Vinorelbine Sales by Region (2017-2022) & (MT) Table 95. Asia Pacific Vinorelbine Sales by Region (2023-2028) & (MT) Table 96. Asia Pacific Vinorelbine Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific Vinorelbine Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America Vinorelbine Sales by Company (2017-2022) & (MT) Table 99. Latin America Vinorelbine Sales Market Share by Company (2017-2022) Table 100. Latin America Vinorelbine Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America Vinorelbine Revenue Market Share by Company (2017-2022) Table 102. Latin America Vinorelbine Sales by Type (2017-2022) & (MT) Table 103. Latin America Vinorelbine Sales by Type (2023-2028) & (MT) Table 104. Latin America Vinorelbine Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America Vinorelbine Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America Vinorelbine Sales by Application (2017-2022) & (MT) Table 107. Latin America Vinorelbine Sales by Application (2023-2028) & (MT) Table 108. Latin America Vinorelbine Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America Vinorelbine Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America Vinorelbine Sales by Country (2017-2022) & (MT) Table 111. Latin America Vinorelbine Sales by Country (2023-2028) & (MT) Table 112. Latin America Vinorelbine Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America Vinorelbine Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa Vinorelbine Sales by Company (2017-2022) & (MT) Table 115. Middle East and Africa Vinorelbine Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa Vinorelbine Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa Vinorelbine Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa Vinorelbine Sales by Type (2017-2022) & (MT) Table 119. Middle East and Africa Vinorelbine Sales by Type (2023-2028) & (MT) Table 120. Middle East and Africa Vinorelbine Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa Vinorelbine Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa Vinorelbine Sales by Application (2017-2022) & (MT) Table 123. Middle East and Africa Vinorelbine Sales by Application (2023-2028) & (MT) Table 124. Middle East and Africa Vinorelbine Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa Vinorelbine Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa Vinorelbine Sales by Country (2017-2022) & (MT) Table 127. Middle East and Africa Vinorelbine Sales by Country (2023-2028) & (MT) Table 128. Middle East and Africa Vinorelbine Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa Vinorelbine Revenue by Country (2023-2028) & (US$ Million) Table 130. Pierre Fabre Pharmaceuticals, Inc. Corporation Information Table 131. Pierre Fabre Pharmaceuticals, Inc. Description and Overview Table 132. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 133. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product and Services Table 134. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine SWOT Analysis Table 135. Pierre Fabre Pharmaceuticals, Inc. Recent Developments Table 136. TEVA Pharms Corporation Information Table 137. TEVA Pharms Description and Overview Table 138. TEVA Pharms Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 139. TEVA Pharms Vinorelbine Product and Services Table 140. TEVA Pharms Vinorelbine SWOT Analysis Table 141. TEVA Pharms Recent Developments Table 142. Hospira, Inc. Corporation Information Table 143. Hospira, Inc. Description and Overview Table 144. Hospira, Inc. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 145. Hospira, Inc. Vinorelbine Product and Services Table 146. Hospira, Inc. Vinorelbine SWOT Analysis Table 147. Hospira, Inc. Recent Developments Table 148. West-Ward Pharmaceuticals Corp. Corporation Information Table 149. West-Ward Pharmaceuticals Corp. Description and Overview Table 150. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 151. West-Ward Pharmaceuticals Corp. Vinorelbine Product and Services Table 152. West-Ward Pharmaceuticals Corp. Vinorelbine SWOT Analysis Table 153. West-Ward Pharmaceuticals Corp. Recent Developments Table 154. Fresenius Kabi Corporation Information Table 155. Fresenius Kabi Description and Overview Table 156. Fresenius Kabi Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 157. Fresenius Kabi Vinorelbine Product and Services Table 158. Fresenius Kabi Vinorelbine SWOT Analysis Table 159. Fresenius Kabi Recent Developments Table 160. EBEWE Pharma (Sandoz A Novartis Division) Corporation Information Table 161. EBEWE Pharma (Sandoz A Novartis Division) Description and Overview Table 162. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 163. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product and Services Table 164. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine SWOT Analysis Table 165. EBEWE Pharma (Sandoz A Novartis Division) Recent Developments Table 166. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information Table 167. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Overview Table 168. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 169. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services Table 170. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine SWOT Analysis Table 171. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments Table 172. Mylan Corporation Information Table 173. Mylan Description and Overview Table 174. Mylan Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 175. Mylan Vinorelbine Product and Services Table 176. Mylan Vinorelbine SWOT Analysis Table 177. Mylan Recent Developments Table 178. Dr. Reddy's Laboratories Corporation Information Table 179. Dr. Reddy's Laboratories Description and Overview Table 180. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 181. Dr. Reddy's Laboratories Vinorelbine Product and Services Table 182. Dr. Reddy's Laboratories Vinorelbine SWOT Analysis Table 183. Dr. Reddy's Laboratories Recent Developments Table 184. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Corporation Information Table 185. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Description and Overview Table 186. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 187. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services Table 188. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine SWOT Analysis Table 189. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Recent Developments Table 190. Nanjing Cuccess Pharmaceutical Co., Ltd Corporation Information Table 191. Nanjing Cuccess Pharmaceutical Co., Ltd Description and Overview Table 192. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 193. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product and Services Table 194. Nanjing Cuccess Pharmaceutical Co., Ltd Recent Developments Table 195. Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information Table 196. Qilu Pharmaceutical (Hainan) Co., Ltd. Description and Overview Table 197. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 198. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product and Services Table 199. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments Table 200. Sinopharm A-Think Pharmaceutical Co., Ltd. Corporation Information Table 201. Sinopharm A-Think Pharmaceutical Co., Ltd. Description and Overview Table 202. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 203. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product and Services Table 204. Sinopharm A-Think Pharmaceutical Co., Ltd. Recent Developments Table 205. Beijing SL Pharm Corporation Information Table 206. Beijing SL Pharm Description and Overview Table 207. Beijing SL Pharm Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 208. Beijing SL Pharm Vinorelbine Product and Services Table 209. Beijing SL Pharm Recent Developments Table 210. Shenzhen Main Luck Pharmaceuticals Inc. Corporation Information Table 211. Shenzhen Main Luck Pharmaceuticals Inc. Description and Overview Table 212. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 213. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product and Services Table 214. Shenzhen Main Luck Pharmaceuticals Inc. Recent Developments Table 215. Shanxi Powerdone Pharmaceutics Co., Ltd. Corporation Information Table 216. Shanxi Powerdone Pharmaceutics Co., Ltd. Description and Overview Table 217. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 218. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product and Services Table 219. Shanxi Powerdone Pharmaceutics Co., Ltd. Recent Developments Table 220. Luoxin Pharmaceutical Group Co., Ltd. Corporation Information Table 221. Luoxin Pharmaceutical Group Co., Ltd. Description and Overview Table 222. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022) Table 223. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services Table 224. Luoxin Pharmaceutical Group Co., Ltd. Recent Developments Table 225. Key Raw Materials Lists Table 226. Raw Materials Key Suppliers Lists Table 227. Vinorelbine Distributors List Table 228. Vinorelbine Customers List Table 229. Research Programs/Design for This Report Table 230. Key Data Information from Secondary Sources Table 231. Key Data Information from Primary Sources List of Figures Figure 1. Vinorelbine Product Picture Figure 2. Global Vinorelbine Sales Market Share by Type in 2021 & 2028 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. Global Vinorelbine Sales Market Share by Application in 2021 & 2028 Figure 6. Breast Cancer Use Case Figure 7. Non-small Cell Lung Cancer Use Case Figure 8. Other Use Case Figure 9. Vinorelbine Report Years Considered Figure 10. Global Vinorelbine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Vinorelbine Market Size 2017-2028 (US$ Million) Figure 12. Global Vinorelbine Sales (2017-2022) & (MT) Figure 13. Global Vinorelbine Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Vinorelbine Sales Market Share by Region (2017-2022) Figure 15. Global Vinorelbine Sales Market Share by Region in 2021 Figure 16. Global Vinorelbine Revenue Market Share by Region in 2017 VS 2021 Figure 17. Global Vinorelbine Sales Share by Manufacturers in 2021 Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Vinorelbine Sales in 2021 Figure 19. Vinorelbine Revenue Share by Manufacturers in 2021 Figure 20. Vinorelbine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Vinorelbine Revenue Share by Type (2017-2022) Figure 22. Global Vinorelbine Revenue Growth Rate by Type in 2017 & 2021 Figure 23. Global Vinorelbine Revenue Share by Application (2017-2022) Figure 24. Global Vinorelbine Revenue Growth Rate by Application in 2017 & 2021 Figure 25. North America Vinorelbine Sales Market Share by Type (2017-2028) Figure 26. North America Vinorelbine Revenue Market Share by Type (2017-2028) Figure 27. North America Vinorelbine Sales Market Share by Application (2017-2028) Figure 28. North America Vinorelbine Revenue Market Share by Application (2017-2028) Figure 29. North America Vinorelbine Sales Share by Country (2017-2028) Figure 30. North America Vinorelbine Revenue Share by Country (2017-2028) Figure 31. U.S. Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 32. Canada Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 33. Europe Vinorelbine Sales Market Share by Type (2017-2028) Figure 34. Europe Vinorelbine Revenue Market Share by Type (2017-2028) Figure 35. Europe Vinorelbine Sales Market Share by Application (2017-2028) Figure 36. Europe Vinorelbine Revenue Market Share by Application (2017-2028) Figure 37. Europe Vinorelbine Sales Share by Country (2017-2028) Figure 38. Europe Vinorelbine Revenue Share by Country (2017-2028) Figure 39. Germany Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 40. France Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 41. U.K. Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 42. Italy Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 43. Russia Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 44. Asia Pacific Vinorelbine Sales Market Share by Type (2017-2028) Figure 45. Asia Pacific Vinorelbine Revenue Market Share by Type (2017-2028) Figure 46. Asia Pacific Vinorelbine Sales Market Share by Application (2017-2028) Figure 47. Asia Pacific Vinorelbine Revenue Market Share by Application (2017-2028) Figure 48. Asia Pacific Vinorelbine Sales Share by Region (2017-2028) Figure 49. Asia Pacific Vinorelbine Revenue Share by Region (2017-2028) Figure 50. China Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 51. Japan Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 52. South Korea Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 53. India Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 54. Australia Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 55. Taiwan Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 56. Indonesia Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 57. Thailand Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 58. Malaysia Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 59. Philippines Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 60. Vietnam Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 61. Latin America Vinorelbine Sales Market Share by Type (2017-2028) Figure 62. Latin America Vinorelbine Revenue Market Share by Type (2017-2028) Figure 63. Latin America Vinorelbine Sales Market Share by Application (2017-2028) Figure 64. Latin America Vinorelbine Revenue Market Share by Application (2017-2028) Figure 65. Latin America Vinorelbine Sales Share by Country (2017-2028) Figure 66. Latin America Vinorelbine Revenue Share by Country (2017-2028) Figure 67. Mexico Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 68. Brazil Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 69. Argentina Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 70. Middle East and Africa Vinorelbine Sales Market Share by Type (2017-2028) Figure 71. Middle East and Africa Vinorelbine Revenue Market Share by Type (2017-2028) Figure 72. Middle East and Africa Vinorelbine Sales Market Share by Application (2017-2028) Figure 73. Middle East and Africa Vinorelbine Revenue Market Share by Application (2017-2028) Figure 74. Middle East and Africa Vinorelbine Sales Share by Country (2017-2028) Figure 75. Middle East and Africa Vinorelbine Revenue Share by Country (2017-2028) Figure 76. Turkey Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 77. Saudi Arabia Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 78. U.A.E Vinorelbine Revenue (2017-2028) & (US$ Million) Figure 79. Vinorelbine Value Chain Figure 80. Vinorelbine Production Process Figure 81. Channels of Distribution Figure 82. Distributors Profiles Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed

Pierre Fabre Pharmaceuticals, Inc. TEVA Pharms Hospira, Inc. West-Ward Pharmaceuticals Corp. Fresenius Kabi EBEWE Pharma (Sandoz A Novartis Division) Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Mylan Dr. Reddy's Laboratories Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Nanjing Cuccess Pharmaceutical Co., Ltd Qilu Pharmaceutical (Hainan) Co., Ltd. Sinopharm A-Think Pharmaceutical Co., Ltd. Beijing SL Pharm Shenzhen Main Luck Pharmaceuticals Inc. Shanxi Powerdone Pharmaceutics Co., Ltd. Luoxin Pharmaceutical Group Co., Ltd.